Literature DB >> 25428782

Does EUS-FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review.

Amy Gillis1, Ilaria Cipollone, Grainne Cousins, Kevin Conlon.   

Abstract

BACKGROUND: Endoscopic ultrasonography with fine needle aspiration (EUS-FNA) has become an integral tool in the diagnosis of pancreatic cystic lesions (PCLs) and the analysis of molecular/DNA abnormalities might improve the accuracy of pre-operative diagnosis. A review was conducted of all studies using EUS-FNA aspirates of PCLs to assess the accuracy and added benefit that molecular analysis provides to cytological analysis.
METHODS: A systematic review of the literature was conducted using PRISMA guidelines and electronic databases: PubMed/SCOPUS/EMBASE/Cochrane/CINAHL. Surgical pathology was used as the definitive reference standard. The QUADAS-2 tool was used for quality assessment.
RESULTS: In total, 162 articles were identified; 12 articles met inclusion/exclusion criteria. Ten studies reported on cytology and 8 studies reported k-ras mutational analysis. 362 patients (of 1115 total) had surgical pathology available. The sensitivity and specificity of cytology was 0.42 and 0.99; the sensitivity and specificity of k-ras was 0.39 and 0.95; and the sensitivity and specificity of the combined test of cytology and k-ras was 0.71 and 0.88, respectively.
CONCLUSIONS: k-ras mutational analysis used as an individual screening test has a poor diagnostic accuracy, as does cytology when used alone. The benefit comes with utilization in a combined fashion. More studies are needed to evaluate the correct sequence and utility of these tests for cyst differentiation.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25428782      PMCID: PMC4402047          DOI: 10.1111/hpb.12364

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  25 in total

Review 1.  Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.

Authors:  Laurens A van der Waaij; Hendrik M van Dullemen; Robert J Porte
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

Review 2.  Pancreatic cyst fluid analysis--a review.

Authors:  Manoop S Bhutani; Vikas Gupta; Sushovan Guha; Dan Ionuţ Gheonea; Adrian Saftoiu
Journal:  J Gastrointestin Liver Dis       Date:  2011-06       Impact factor: 2.008

3.  A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.

Authors:  Jayaprakash Sreenarasimhaiah; Luis F Lara; Saad F Jazrawi; Carlton C Barnett; Shou-jiang Tang
Journal:  JOP       Date:  2009-03-09

4.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

Authors:  William R Brugge; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; Barbara A Centeno; Tara Szydlo; Susan Regan; Carlos Fernandez del Castillo; Andrew L Warshaw
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

5.  Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.

Authors:  Nicole C Panarelli; Raanan Sela; Andrew M Schreiner; John P Crapanzano; David S Klimstra; Felice Schnoll-Sussman; Mark B Pochapin; Rhonda K Yantiss
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

6.  A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.

Authors:  Renata Talar-Wojnarowska; Marek Pazurek; Lukasz Durko; Malgorzata Degowska; Grazyna Rydzewska; Jacek Smigielski; Adam Janiak; Marek Olakowski; Pawel Lampe; Piotr Grzelak; Ludomir Stefanczyk; Beata Smolarz; Ewa Malecka-Panas
Journal:  Pancreatology       Date:  2012-08-10       Impact factor: 3.996

7.  Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis.

Authors:  Jian Shen; William R Brugge; Christopher J Dimaio; Martha B Pitman
Journal:  Cancer       Date:  2009-06-25       Impact factor: 6.860

8.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

Review 9.  Update on pancreatic cyst fluid analysis.

Authors:  Matthew Rockacy; Asif Khalid
Journal:  Ann Gastroenterol       Date:  2013

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  20 in total

1.  Should pancreas cyst fluids be divided into two for cytological diagnosis and biochemical tests?

Authors:  Davut Şahin; Bahattin Çiçek; İlkser Akpolat; Gürhan Şişman; Nilgün Tekkeşin
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 2.  Molecular Diagnostics and Testing for Pancreatic Cysts.

Authors:  Jaime de la Fuente; Shounak Majumder
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-27

3.  Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.

Authors:  Sandra Faias; Marlene Duarte; Cristina Albuquerque; João Pereira da Silva; Ricardo Fonseca; Ruben Roque; Antonio Dias Pereira; Paula Chaves; Marília Cravo
Journal:  Dig Dis Sci       Date:  2018-05-24       Impact factor: 3.199

Review 4.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

5.  Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms.

Authors:  Jiang Liu; Ying Xing; Liqi Sun
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

Review 6.  Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic cysts by combined cytopathology and cystic content analysis.

Authors:  Amanda K Martin; Zhongren Zhou
Journal:  World J Gastrointest Endosc       Date:  2015-10-25

Review 7.  Review of the diagnosis and management of intraductal papillary mucinous neoplasms.

Authors:  Stefano Crippa; Paolo G Arcidiacono; Francesco De Cobelli; Massimo Falconi
Journal:  United European Gastroenterol J       Date:  2019-12-09       Impact factor: 4.623

8.  Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing.

Authors:  Eri Kameta; Kazuya Sugimori; Takashi Kaneko; Tomohiro Ishii; Haruo Miwa; Takeshi Sato; Yasuaki Ishii; Soichiro Sue; Tomohiko Sasaki; Yuki Yamashita; Wataru Shibata; Naomichi Matsumoto; Shin Maeda
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

Review 9.  Management of Incidental Pancreatic Cystic Lesions.

Authors:  Christian Jenssen; Stefan Kahl
Journal:  Viszeralmedizin       Date:  2015-02

10.  Role of emerging molecular markers in pancreatic cyst fluid.

Authors:  Mohammad Al-Haddad
Journal:  Endosc Ultrasound       Date:  2015 Oct-Dec       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.